Amikacin Sulfate Injection
Product Images NDC 83301-0022

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Amikacin Sulfate (NDC 83301-0022). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mullan Pharmaceutical Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Amikacin 01)

Chemical structure of Amikacin Sulfate, depicting its molecular composition including sugar rings and sulfate groups as represented in the molecular diagram.*

FDA Label Image

Principal Display Panel (2 mL Vial Carton)

Amikacin Sulfate Injection, USP 500 mg/2 mL (250 mg/mL) is presented in a carton for 10 single-dose 2 mL vials. The label indicates use for intramuscular or intravenous administration. The product is manufactured by Mullan Pharmaceutical Inc. and QILU Pharmaceutical Co., Ltd. Storage instructions and dosage details are included on the label.*

FDA Label Image

Principal Display Panel (4 mL Vial Carton)

Amikacin Sulfate Injection, USP 1 gram/4 mL (250 mg/mL) single-dose vials carton for intramuscular or intravenous use. Pack contains 10 vials of 4 mL each. Labeled for Mullan Pharmaceutical Inc., manufactured by QILU Pharmaceutical Co., Ltd. The label includes dosage and storage information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.